Search
-
Accelerating with Gen AI: 3 client stories to inspire you
Revisit our on demand webinar to hear inspirational stories of clients leveraging our best-in-class generative AI research solutions.
-
U.S. Biosimilars: Greater Access and New Commercial Models
Read more about the primary considerations that manufacturers – of both biosimilars and originator products – must factor into strategic plans going forward.
-
London takes first place in 2025 World's Best Cities report
The definitive benchmarking of global cities, produced by Resonance with research by Ipsos, surveyed more than 22,000 people in 30 countries to find the best of the best.
-
GLP-1 drugs are creating new business opportunities
With a total understanding of the science, the consumers and the sectors, Ipsos can help your business ask the right questions about GLP-1s — and find the right answers.
-
Ipsos and Haleon: thinking in the future tense
Learn how Ipsos and Haleon focused on having a futures mindset to identify global drivers of change while centering the human aspect of a changing world.
-
[WEBINAR] Beyond Checkpoints: Next-Gen Therapeutics for Solid Tumors
Don’t miss out on hearing expert insights about the future of oncology therapeutics.
-
CIMA DE&I Connect: AI Trends in Advertising
Join Ipsos’ Mercedes Bender as she moderates an insightful panel discussion exploring the intersection of artificial intelligence (AI) and diversity, equity, and inclusion (DEI) within the advertising industry.
-
Ipsos Update – December 2024
Security, Inflation, Perils of Perception … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
Inflation rates may be falling, but people expect further price rises
In the seventh edition of the Ipsos Cost of Living Monitor we find, despite falling inflation rates, people are still feeling the pressure.